Paul H Naylor
机构: Associate Adjunct Professor of Internal Medicine/Gastroenterology
主页: google.com
每年引用次数
引用次数
引用: 3,385
H-指数: 32
I10-指数 : 78
出版物: 292
PROGRESS IN THE DEVELOPMENT OF A P17 BASED HIV VACCINE-SAFETY AND POTENTIAL EFFICACY OF THE HGP-30 SYNTHETIC PEPTIDE VACCINE IN HUMANS
AL Goldstein , PH Naylor , PS Sarin , C OTOOLE
AIDS RESEARCH AND HUMAN RETROVIRUSES 8 ( 5) 939 -939
4
1992
PROGRESS IN THE DEVELOPMENT OF A P17 BASED HIV VACCINE-IMMUNOGENICITY OF HGP-30 IN HUMANS
AL Goldstein , PH Naylor , PS Sarin , JE Kirkley
AIDS RESEARCH AND HUMAN RETROVIRUSES 7 ( 2) 154 -154
4
1991
Brazilian pemphigus foliaceus patients have elevated thymosin alpha-1 levels
JT Roscoe , PH Naylor , LA Diaz , RS Labib
Clinical Research. Part One 33 ( 2) 302 -302
4
1985
Inhibition of HBV HEPG2 anchorage-independent growth is enhanced by the combination of thymosin alpha 1 and interferon alpha
JA Moshier , MG Mutchnick , J Dosescu , J Merline
Hepatology 20 284A -284A
3
1994
IMMUNE-ENDOCRINE ACTIVITIES OF GREEN BARLEY LEAF EXTRACT (BLE)-REGULATION OF PROLACTIN AND INTERLEUKIN-2 RELEASE INVITRO
M Badamchian , PH Naylor , BL Spangelo , MP Strickler
FASEB JOURNAL 5 ( 4) A567 -A567
3
1991
Response to combination treatment in African-American patients with chronic hepatitis C is significantly lower compared to Caucasians.
FA Siddiqui , MN Ehrinpreis , PH Naylor , R Dhar
Hepatology 34 ( 4) 581A -581A
2
2001
The vaccine quest
Allan L Goldstein , PH Naylor
Focus 6 1 -2
2
1991
Thymosin and thymosin-like preparations
AL Goldstein , TLK Low , NR Hall , PH Naylor
Thymcc Fartor Therapy 9 -20
2
1984
Differences in side effect profiles and response to combination ribavirin and interferon A2B (IFN) therapy between Caucasians and African Americans with chronic hepatitis C.
G Alawad , PH Naylor , A Hemacha , K Jamma
Hepatology 32 ( 4) 368A -368A
1
2000
Serum HCV RNA levels as determinants for dose escalation of interferon: Results from studies in an urban clinic population.
RR Peleman , PH Naylor , MN Ehrinpreis , MG Nathani
Hepatology 28 ( 4) 370A -370A
1
1998
Thymosin alpha 1 associated clearance of serum HBV DNA occurs in patients with chronic hepatitis B (CHB) who have DNA levels less than 2500 pg/ml and is accompanied by a flare in serum ALT.
PH Naylor , MG Nathani , MG Mutchnick
FASEB JOURNAL 10 ( 6) 33 -33
1
1996
Comparison of two HBV-DNA hybridization assays of sera from patients completing a clinical trial of thymosin alpha (1)(T alpha (1)) in chronic hepatitis B (CHB).
PH Naylor , M Nathani , R Peleman , MN Ehrinpreis
Gastroenterology 110 ( 4) A1276 -A1276
1
1996
Correction: Cellular Levels of Thymosin Immunoreactive Peptides are Linked to Proliferative Events: Evidence for a Nuclear Site of Action
CN Conteas , MG Mutchnick , KC Palmer , FE Weller
Proceedings of the National Academy of Sciences 87 ( 14) 5587a -5587
1990
PROGRESS IN THE DEVELOPMENT OF HGP-30-AN HIV-P17 BASED VACCINE
AL Goldstein , PH Naylor , CJ Gibbs , PS SARIN
AIDS RESEARCH AND HUMAN RETROVIRUSES 6 ( 1) 39 -40
1
1990
Hamster renal adenocarcinoma: Effect of diethylstilbestrol on immune and endocrine status
PH Naylor , AL Goldstein , CA Villee
The Role of Drugs and Electrolytes in Hormonogenesis 295 -295
1
1984
THYMOSIN INDUCED INCREASE IN CYCLIC-GMP IN MURINE LYMPHOCYTES
PH Naylor , GB Thurman , AL Goldstein
FEDERATION PROCEEDINGS 36 ( 3) 688 -688
1
1977
Serum ALT levels as predictors of Chronic Hepatitis C in urban primary care clinic populations.
MG Mutchnick , PH Naylor , JR Merline , MJ Upfal
HEPATOLOGY 34 ( 4) 563A -563A
2001
Induction interferon treatment of African-Americans with chronic hepatitis C results in an enhanced response comparable to caucasians given standard interferon therapy.
F Siddiqui , PH Naylor , MN Ehrinpreis , R Peleman
GASTROENTEROLOGY 116 ( 4) A820 -A820
1999
Presence of Hepatitis B Virus Core Antibodies (Anti-HBC) in Chronic Hepatitis C Patients is Predictive of a Decreased End of Treatment Response (ETR) to Interferon
N Ullah , FA Siddiqui , PH Naylor , JL Kinzie
HEPATOLOGY-BALTIMORE THEN ORLANDO- 30 138 -138
1999
Three negative PCR for HCV RNA at intervals of one month are not adequate to predict a sustained response to interferon.
MG Nathani , PH Naylor , MN Ehrinpreis , JL Kinzie
HEPATOLOGY 28 ( 4) 702A -702A
1998